• Home Page
  • About Us
  • Our Technology
  • Current Pipeline
  • Media & Publications
  • News
  • Contact Us
  • Careers
Events
2 years ago

Participation at BIO-Europe 23

Events
2 years ago

Plasfer@ISTH2023 Congress (Montreal, Canada)

Business Development
2 years ago

Plasfer opens a US-based subsidiary in St. Louis, MO

Business Development
2 years ago

Plasfer appoints Christopher Bethel as Chief Innovation Officer

Business Development
3 years ago

International Patent Application

Business Development
4 years ago

EU Patent granted

Business Development
4 years ago

Plasfer appoints Rosario Billetta as Chief Operating Officer

Business Development
5 years ago

Plasfer secures €0.5 million ($0.57 million) pre-seed equity financing

Events
6 years ago

Participation at BIO-Europe 19

Events
6 years ago

Participation at 19th Annual Biotech in Europe FORUM

Plasfer Srl
Vat. IT03476160548
info@plasfer.bio

Italian HQ
Via San Damiano, 14
06121, Perugia (Umbria)
Italy

Italian R&D Unit
Neurobiotech – Polo d’Innovazione Tecnologica
Viale Thomas Alva Edison
81100 Caserta (CE) Italy

United States HQ
Biogenerator – 4340 Duncan Ave
St. Louis, MO, 63110 (U.S.A.)

Plasfer Srl is a pre-clinical stage biopharmaceutical company specialized in the development of a transformative cell-based therapy using a proprietary platform technology able to engineer platelet concentrate into highly innovative, life-changing medicines.

Browse Website
  • Home Page
  • About Us
  • Our Technology
  • Current Pipeline
  • Media & Publications
  • News
  • Contact Us
  • Careers
Follow Us
LinkedIn
This website uses cookies to improve your experience. If you continue to use this site, you agree with it.